Bruker Q4 Adj. EPS $0.70 Beats $0.68 Estimate, Sales $854.50M Beat $807.49M Estimate
Portfolio Pulse from Benzinga Newsdesk
Bruker Corporation (NASDAQ:BRKR) reported Q4 adjusted EPS of $0.70, surpassing the $0.68 estimate, and sales of $854.50M, exceeding the $807.49M estimate. This represents a 5.41% decrease in EPS and a 20.62% increase in sales year-over-year.
February 13, 2024 | 12:05 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Bruker Corporation reported a Q4 adjusted EPS of $0.70, beating estimates, and sales of $854.50M, also above expectations. Despite a year-over-year decrease in EPS, sales saw significant growth.
Bruker's Q4 earnings and sales beat estimates, indicating strong financial performance. The EPS beat and significant sales growth are likely to positively impact investor sentiment and BRKR's stock price in the short term. Although there's a slight decrease in EPS compared to last year, the substantial sales increase and beating estimates are more impactful factors.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100